Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Aug 29;28(10):1687–1693. doi: 10.1158/1055-9965.EPI-19-0008

Figure 1.

Figure 1.

Relative abundance of the major phyla comparing subjects with no dysplasia or LGD to those with HGD or EAC. Compared to NDBE/LGD subjects, those with HGD or EAC had decreased Firmicutes (p=0.04) and increased Proteobacteria (p=0.04).